Choroid plexus cell replacement therapy (Living Cell Technologies)

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameChoroid plexus cell replacement therapy (Living Cell Technologies)
Drug Alias NameNeurological disorders cell therapy - Living Cell TechnologiesNeurotrophinCellNTCELL
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Choroid plexus cell therapy
Mechanisms of ActionCell replacementsNerve growth factor receptors agonists
TargetsNerve growth factor receptors
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew Zealand
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLiving Cell Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLiving Cell Technologies
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A